Furthermore, Pharmaceutical Equipment Testing  market research report intensely analyses the potential of the market with respect to existing scenario and the future prospects by considering all industry aspects of ABC industry. Not to mention, to do well in this competitive market place, market research report plays a very central role by offering important and consequential market insights for the business. With a full devotion and commitment, Pharmaceutical Equipment Testing  market research report has been presented with the best realistic service and recommendations which can be trusted confidently. To grow higher in this competitive era, it’s better to choose market analysis report.

Data Bridge Market Research analyses that the pharmaceutical equipment testing market which is USD 10.0 billion in 2022, is expected to reach USD 15.1 billion by 2030, at a CAGR of 5% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

 

 

Pharmaceutical testing includes API formulation, dosage form testing and processing, friability testing, and many other applications. Pharmaceutical testing occurs at all stages of the formulation, development, and manufacturing processes.Some of the major players operating in the medical gases-equipment market are Linde plc, Air Products Inc., Air Liquide, Atlas Copco AB, Messer SE & Co. KGaA, GCE Group, Praxair Technology, Inc., SOL SpA, MATHESON TRI-GAS, INC., Rotarex, Medical Gas Solutions Inc., Amico Group of Companies, BeaconMedaes, DCC plc, TAIYO NIPPON SANSO CORPORATION, Ohio Medical, Airgas, Inc., and Allied Healthcare Products, Inc., among others.

 

 

SGS Société Générale de Surveillance SA (Switzerland)

 

Envigo (U.S.)

 

Thermo Fisher Scientific Inc. (U.S.)

 

Pace Analytical Services, LLC (U.S.)

 

Intertek Group plc (U.K.)

 

Dynalabs (U.S.)

 

RD Laboratories Inc. (U.S.)

 

ADPEN Laboratories Inc. (U.S.)

 

West Pharmaceutical Services, Inc. (U.S.)

 

Boston Analytical (U.S.)

 

Microbac Laboratories Inc. (U.S.)

 

Charles River Laboratories (U.S.)

 

ARL Bio Pharma, Inc. (U.S.)

 

TASI Group (U.S.)

 

 

 

An increase in R&D activities, collaborations, and strategic partnerships is expected to drive market growth. For instance, in November 2021, Alcami Corporation, Inc. announced the signing of a master laboratory services agreement with Novavax. With this agreement, Novavax immediately secured full-time equivalent (FTE) resources to provide analytical testing support for its recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant.

 

One of the major factors driving the growth of this market is the increase in demand for high-quality medicines. The prevalence of various diseases such as cancer, cardiovascular disorders, respiratory disorders, and diabetes is increasing at an alarming rate around the world. This has resulted in increased R&D activities across various regions, fueling the growth of the global pharmaceutical equipment testing market during the forecast period.

 

 

According to the FDA Drug Recall Statistics posted on July 2021, approximately 1,279 drugs are recalled globally each year, with 94% of Food and Drug Administration (FDA) drug recalls occurring in the United States, followed by 4% of FDA drug recalls occurring in Canada. The FDA issued 12,028 drug recalls in the United States between 2012 and 2021. This highlights the importance of testing products and ensuring public safety before they are marketed. Medicines are designed to improve outcomes in humans and animals because poor quality medicines harm patients' health and funding systems. As a result, analytical testing is critical in ensuring the safety and efficacy of drugs.

 

 

 

Part 01: Executive Summary

 

Part 02: Scope of the Report

 

Part 03: Global Pharmaceutical Equipment Testing  Market Landscape

 

Part 04: Global Pharmaceutical Equipment Testing  Market Sizing

 

Part 05: Global Pharmaceutical Equipment Testing  Market Segmentation By Product

 

Part 06: Five Forces Analysis

 

Part 07: Customer Landscape

 

Part 08: Geographic Landscape

 

Part 09: Decision Framework

 

Part 10: Drivers and Challenges

 

Part 11: Market Trends

 

Part 12: Vendor Landscape

 

Part 13: Vendor Analysis

 

 

 

 

 

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

 

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

 

 

Data Bridge Market Research

 

US: +1 888 387 2818

 

United Kingdom: +44 208 089 1725

 

Hong Kong: +852 8192 7475

 

Email: – sopan.gedam@databridgemarketresearch.com